Envestnet Asset Management Inc Viking Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

$281 Billion
Q2 2024

A detailed history of Envestnet Asset Management Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 20,354 shares of VKTX stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,354

Previous 19,679 3.43%

Holding current value

$1.28 Million

Previous $1.61 Million 33.17%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$47.39 - $80.2 $31,988 - $54,135	675 Added 3.43%	20,354 $1.08 Million
Q1 2024 May 13, 2024	BUY	$17.4 - $94.5 $342,414 - $1.86 Million	19,679 New	19,679 $1.61 Million
Q2 2023 Aug 04, 2023	SELL	$14.84 - $24.79 $14,068 - $23,500	-948 Reduced 5.39%	16,626 $269,000
Q1 2023 May 11, 2023	BUY	$8.08 - $17.33 $18,446 - $39,564	2,283 Added 14.93%	17,574 $292,000
Q4 2022 Feb 07, 2023	SELL	$2.72 - $9.4 $2,967 - $10,255	-1,091 Reduced 6.66%	15,291 $143,000
Q3 2022 Nov 10, 2022	SELL	$2.55 - $3.89 $5,033 - $7,678	-1,974 Reduced 10.75%	16,382 $45,000
Q2 2022 Aug 03, 2022	BUY	$2.11 - $3.15 $38,731 - $57,821	18,356 New	18,356 $53,000
Q4 2021 Feb 04, 2022	SELL	$4.6 - $6.72 $142,830 - $208,656	-31,050 Closed	0 $0
Q3 2021 Oct 07, 2021	BUY	$5.58 - $7.04 $7,906 - $9,975	1,417 Added 4.78%	31,050 $195,000
Q2 2021 Aug 04, 2021	BUY	$5.19 - $6.73 $3,513 - $4,556	677 Added 2.34%	29,633 $178,000
Q1 2021 May 04, 2021	BUY	$5.74 - $9.67 $49,702 - $83,732	8,659 Added 42.66%	28,956 $183,000
Q4 2020 Feb 02, 2021	SELL	$5.3 - $6.71 $42,574 - $53,901	-8,033 Reduced 28.36%	20,297 $114,000
Q3 2020 Oct 09, 2020	SELL	$5.73 - $8.11 $20,009 - $28,320	-3,492 Reduced 10.97%	28,330 $165,000
Q2 2020 Jul 08, 2020	SELL	$4.35 - $8.08 $34,043 - $63,234	-7,826 Reduced 19.74%	31,822 $229,000
Q1 2020 Apr 23, 2020	SELL	$3.45 - $7.95 $1,538 - $3,545	-446 Reduced 1.11%	39,648 $186,000
Q4 2019 Feb 11, 2020	BUY	$6.38 - $8.73 $12,026 - $16,456	1,885 Added 4.93%	40,094 $322,000
Q3 2019 Oct 17, 2019	SELL	$6.55 - $8.6 $3,130 - $4,110	-478 Reduced 1.24%	38,209 $263,000
Q2 2019 Aug 02, 2019	BUY	$7.67 - $10.63 $10,945 - $15,169	1,427 Added 3.83%	38,687 $321,000
Q1 2019 May 10, 2019	BUY	$7.58 - $9.94 $114,647 - $150,342	15,125 Added 68.33%	37,260 $370,000
Q4 2018 Feb 13, 2019	BUY	$7.16 - $16.21 $158,486 - $358,808	22,135 New	22,135 $169,000

Others Institutions Holding VKTX

# of Institutions

442

Shares Held

63.3M

Call Options Held

6.23M

Put Options Held

2.97M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.83B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Viking Therapeutics, Inc. Transaction History